A Critical Review on Analytical Methods for Recently Approved FDC Drugs: Pregabalin and Etoricoxib

References

• Blommel, M. L.; Blommel, A. L. Pregabalin: An Antiepileptic Agent Useful for Neuropathic Pain. Am. J. Health. Syst. Pharm. 2007, 64, 1475–1482. DOI: 10.2146/ajhp060371.
   PubMed Web of Science ®Google Scholar
• Micó, J. A.; Prieto, R. Elucidating the Mechanism of Action of Pregabalin: α(2)δ as a Therapeutic Target in Anxiety. CNS Drugs 2012, 26, 637–648. DOI: 10.2165/11634510-000000000-00000.
   PubMed Web of Science ®Google Scholar
• Inamdar, S. Z.; Joseph, R. P.; Pradeepti, K.; Ashwini, N.; Kulkarni, R. V. Etoricoxib Induced Skin Rashes: Case Report. IJOPP 2017, 10, 227–229. DOI: 10.5530/ijopp.10.3.46.
   Google Scholar
• Takemoto, J.; Reynolds, J.; Remsberg, C.; Vega-Villa, K.; Davies, N. Clinical Pharmacokinetic and Pharmacodynamic Profile of Etoricoxib. Clin. Pharmacokinet. 2008, 47, 703–720. 10.1007/s40262-017-0604-7
   PubMed Web of Science ®Google Scholar
• Escudero-Contreras, A.; Cervantes, J. V. M.; Collantes-Estevez, E. Update on the Clinical Pharmacology of Etoricoxib, a Potent Cyclooxygenase-2 Inhibitor. Fut. Rheumatol. 2007, 2, 545–565. DOI: 10.2217/17460816.2.6.545.
   Google Scholar
• Kim, K. H.; Lim, S. H.; Shim, C. R.; Park, J.; Song, W. H.; Kwon, M. C.; Lee, J. H.; Park, J. S.; Choi, H. G. Development of a Novel Controlled-Release Tablet of Pregabalin: Formulation Variation and Pharmacokinetics in Dogs and Humans. Drug Des. Devel. Ther. 2020, 14, 445–456. DOI: 10.2147/DDDT.S222505.
   PubMed Web of Science ®Google Scholar
• Prajapati, S.; Dharamsi, A. Formulation Development and Optimization of Floating Matrix Tablet of Pregabalin. Indian J. Nov. Drug Deliv. 2014, 6, 236–246.
   Google Scholar
• Qin, C.; Wu, M.; Xu, S.; Wang, X.; Shi, W.; Dong, Y.; Yang, L.; He, W.; Han, X.; Yin, L. Design and Optimization of Gastro-Floating Sustained-Release Tablet of Pregabalin: In Vitro and in Vivo Evaluation. Int. J. Pharm. 2018, 545, 37–44. DOI: 10.1016/j.ijpharm.2018.04.011.
   PubMedGoogle Scholar
• Jain, H.; Patel, P.; Gohel, M.; Upadhyay, U. Formulation and Evaluation of Pregabalin Sustained Release Tablets. Indo Am. J. Pharm. Sci. 2016, 3, 1316–1321.
   Web of Science ®Google Scholar
• Ben-Menachem, E. Pregabalin Pharmacology and Its Relevance to Clinical Practice. Epilepsia 2004, 45, 13–18. DOI: 10.1111/j.0013-9580.2004.455003.x.
   PubMed Web of Science ®Google Scholar
• Katare, V.; Bhutkar, M. A.; Kumbhar, A. P.; Pol, S. K.; Katare, P. Formulation and Evaluation of Sustained Release Matrix Tablets of Pregabalin. Res. J. Pharm. Technol. 2013, 6, 1190–1194.
   Google Scholar
• Patel, D.; Patel, M. Optimization of Fast Dissolving Etoricoxib Tablets Prepared by Sublimation Technique. Indian J. Pharm. Sci. 2008, 70, 71–76. DOI: 10.4103/0250-474X.40335.
   PubMed Web of Science ®Google Scholar
• Shahi, S. R.; Agrawal, G. R.; Shinde, N. V.; Shaikh, S. A.; Shaikh, S. S.; Somani, V. G.; Shamkuvar, P. B.; Kale, M. A. Formulation and in Vitro Evaluation of Oro-Dispersible Tablets of Etoricoxib with Emphasis on Comparative Functionality Evaluation of Three Classes of Superdisintegrants. Rasayan J. Chem. 2008, 1, 292–300.
   Google Scholar
• Karthikeyini, C. S.; Abirami, A.; Sundar, S. N. Formulation of Extended Release of Etoricoxib Tablets by Hydrophilic and Hydrophobic Polymers. Int. J. Adv. Pharm. Biol. Chem. 2012, 1, 238–241.
   Google Scholar
• Senthilkumar, K.; Vijaya, C. Formulation Development of Mouth Dissolving Film of Etoricoxib for Pain Management. Adv. Pharm. 2015, 2015, 1–11. DOI: 10.1155/2015/702963.
   Google Scholar
• Ashokraj, Y.; Daroi, A.; Gupta, R.; Khanolkar, A.; Kulkarni, A.; Laud, S.; Pokale, M.; Shedge, S.; Date, P. Discriminatory Dissolution Method Development and Validation of Etoricoxib Tablets. Dissolution Technol. 2016, 23, 30–34. DOI: 10.14227/DT230216P30.
   Web of Science ®Google Scholar
• Thorat, S. M.; Chemate, S. Formulation and Development of Capsule in Capsule Drug Delivery System for Biphasic Delivery of Etoricoxib. Int. J. Pharm. Pharm. Res. 2016, 6, 68–78.
   Google Scholar
• Mishra, B.; Mohanty, B. Once Daily Immediate-and Extended-Release Bilayer Tablets of Etoricoxib: A Study on the Release Kinetics. Int. J. App. Pharm. 2019, 11, 230–235. DOI: 10.22159/ijap.2019v11i5.31638.
   PubMedGoogle Scholar
• Frampton, J.; Foster, R. Pregabalin: In the Treatment of Postherpetic Neuralgia. Drugs 2005, 65, 111–118. DOI: 10.2165/00003495-200565010-00011.
   PubMed Web of Science ®Google Scholar
• Taylor, C. P.; Angelotti, T.; Fauman, E. Pharmacology and Mechanism of Action of Pregabalin: The Calcium Channel Alpha2-Delta (Alpha2-Delta) Subunit as a Target for Antiepileptic Drug Discovery. Epilepsy Res. 2007, 73, 137–150. DOI: 10.1016/j.eplepsyres.2006.09.008.
   PubMed Web of Science ®Google Scholar
• Stahl, S. M.; Porreca, F.; Taylor, C. P.; Cheung, R.; Thorpe, A. J.; Clair, A. The Diverse Therapeutic Actions of Pregabalin: Is a Single Mechanism Responsible for Several Pharmacological Activities? Trends Pharmacol. Sci. 2013, 34, 332–339. DOI: 10.1016/j.tips.2013.04.001.
   PubMed Web of Science ®Google Scholar
• Cochrane, D. J.; Jarvis, B.; Keating, G. M. Etoricoxib. Drugs 2002, 62, 2637–2651. DOI: 10.2165/00003495-200262180-00006.
   PubMed Web of Science ®Google Scholar
• Onal, A.; Sagirli, O. Spectrophotometric and Spectrofluorimetric Methods for the Determination of Pregabalin in Bulk and Pharmaceutical Preparation. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2009, 72, 68–71. DOI: 10.1016/j.saa.2008.08.009.
   PubMed Web of Science ®Google Scholar
• Nagaraju, K. S.; Rao, B. S.; Kiran, B. V. Development, Validation & Stress Degradation Studies of Pregabalin by High Performance Liquid Chromatography. Int. J. Pharm. Sci. Res. 2013, 4, 2782–2788. 10.13040/IJPSR.0975-8232.4(7).2782-88.
   Google Scholar
• Manjushree, N.; Chakraborty, A.; Shashidhar, K.; Narayanaswamy, S. A Review of the Drug Pregabalin. Int. J. Basic Clin. Pharmacol. 2015, 4, 601–605. DOI: 10.18203/2319-2003.ijbcp20150359.
   Google Scholar
• Hammad, S. F.; Abdallah, O. M. Optimized and Validated Spectrophotometric Methods for the Determination of Pregabalin in Pharmaceutical Formulation Using Ascorbic Acid and Salicylaldehyde. J. Am. Sci. 2012, 8, 118–124.
   Google Scholar
• Gujral, R. S.; Haque, S. M.; Shanker, P. Development and Validation of Pregabalin in Bulk, Pharmaceutical Formulations and in Human Urine Samples by UV Spectrophotometry. Int. J. Biomed. Sci. 2009, 5, 175–180.
   PubMedGoogle Scholar
• Rizk, M.; Elshahed, M.; Attia, A.; Farag, A. Spectrophotometric Determination of Pregabalin Using N-(1-Naphthyl) Ethylenediamine, as UV Labeling Reagent. Int. J. Pharm. Bio. Sci. 2015, 5, 152–162.
   Google Scholar
• Bali, A.; Gaur, P. A Novel Method for Spectrophotometric Determination of Pregabalin in Pure Form and in Capsules. Chem. Cent. J. 2011, 5, 1–7. 10.1186/1752-153X-5-59.
   PubMedGoogle Scholar
• Walash, M. I.; Belal, F. F.; El-Enany, N. M.; El-Maghrabey, M. H. Utility of Certain Nucleophilic Aromatic Substitution Reactions for the Assay of Pregabalin in Capsules. Chem. Cent. J. 2011, 5, 1–10. 10.1186/1752-153X-5-36.
   PubMedGoogle Scholar
• Patil, D. D.; Patil, M. S.; Wani, Y. B. Spectrophotometric Method for Pregabalin Determination: An Experimental Design Approach for Method Development. J. Assoc. Arab Univ. Basic Appl. Sci. 2016, 21, 31–37. DOI: 10.1016/j.jaubas.2015.03.002.
   Google Scholar
• Walash, M. I.; Belal, F.; El-Enany, N.; El-Maghrabey, M. H. Simple and Sensitive Spectrofluorimetric Method for the Determination of Pregabalin in Capsules through Derivatization with Fluorescamine. Luminescence 2011, 26, 342–348. DOI: 10.1002/bio.1235.
   PubMed Web of Science ®Google Scholar
• Saleh, H. M.; EL-Henawee, M. M.; Ragab, G. H.; Mohamed, O. F. Spectrophotometric and Spectrofluorimetric Determination of Pregabalin via Condensation. Int. J. Pharm. Chem. Biol. Sci. 2014, 4, 738–747.
   Google Scholar
• Varik, S.; Walke, T. Spectrophotometric Determination of Pregabalin from the Capsule Dosage Form Based on Its Micellar Catalyzed Reaction with Sanger’s Reagent. Int. J. Res. Pharm. Biomed. Sci. 2013, 4, 1051–1054.
   Google Scholar
• Najam, R.; Shah, G. M.; Andrabi, S. M. A. Kinetic Spectrophotometric Determination of an Important Pharmaceutical Compound. J. Anal. Sci. Technol. 2013, 4, 22–29. DOI: 10.1186/2093-3371-4-22.
   Google Scholar
• Gupta, C.; Puri, R.; Hussain, A.; Jain, S. Development and Validation of Ninhydrin Based Colorimetric Spectrophotometric Assay for Determination of Pregabalin in Different Dissolution Mediums. Eurasian J. Anal. Chem. 2013, 8, 90–98.
   Google Scholar
• Salem, H. Analytical Study for the Charge-Transfer Complexes of Pregabalin. E-J. Chem. 2009, 6, 332–340. DOI: 10.1155/2009/194653.
   Web of Science ®Google Scholar
• Bostjan, M.; Tomaz, V. A Simple High-Throughput Method for Determination of Antiepileptic Analogues of γ-Aminobutiric Acid in Pharmaceutical Dosage Forms Using Microplate Fluorescence Reader. Chem. Pharm. Bull. 2013. 10.1248/cpb.13-00322.
   Web of Science ®Google Scholar
• Sowjanya, K.; Thejaswini, J. C.; Gurupadayya, B. M.; Indu Priya, M. Spectrophotometric Determination of Pregabalin Using 1, 2-Napthaquinone-4-Sulfonic Acid Sodium and 2, 4 Dinitrophenyl Hydrazine in Pharmaceutical Dosage Form. Der Pharm. Lett. 2011, 3, 47–56.
   Google Scholar
• Sowjanya, K.; Thejaswini, J. C.; Gurupadayya, B. M.; Indupriya, M. Spectrophotometric Determination of Pregabalin Using Gibb’s and MBTH Reagent in Pharmaceutical Dosage Form. Der Pharm. Chem. 2011, 3, 112–122.
   Google Scholar
• Omar, F. K.; Mahmoud, H. A.; Ahmad, N. R. Indirect Spectrophotometric Method for Estimation of Pregabalin in Pharmaceutical Preparations. Syst. Rev. Pharm. 2020, 11, 32–35. 10.31838/srp.2020.4.07.
   Google Scholar
• Pawar, P. Y.; Zanje, L. S.; Tambe, S. S.; Nandgaonkar, A. U.; Funde, P. V.; Vyavhare, A. A. Simultaneous Estimation of Pregabalin and Paracetamol by UV Spectroscopic Method in Bulk and Tablet Formulation. World J. Pharm. Pharm. Sci. 2014, 3, 762–780.
   Google Scholar
• Santosh, C.; Sandeep, S.; Pingle, A.; Neelam, D.; Kshirsagar, S. Development and Validation of UV Spectrophotometric Method for Estimation of Pregabalin. Asian J. Pharm. Anal. 2019, 9, 15–18. DOI: 10.5958/2231-5675.2019.00005.X.
   Web of Science ®Google Scholar
• Oommen, M.; Eapen, S.; Yellina, H.; Sheeja, V. UV-Vis Spectrophotometric Method for Estimation of Pregabalin and Methylcobalamin in Bulk and Capsule Dosage Form. Int. J. Pharm. Res. Life Sci. 2014, 2, 6–15.
   Google Scholar
• Kaur, N.; Mittal, K.; Nagar, R.; Nepali, K.; Thakkar, A. A Senstive Spectrophotometric Method for the Determination of Pregabalin in Pure Drug and Pharmaceutical Formulations through Benzoylation. Int. Res. J. Pharm. 2010, 1, 175–180.
   Google Scholar
• Patel, N.; Rajyaguru, H.; Patel, P. Development and Validation of First Order Derivative Spectrophotometric Method for Simultaneous Estimation of Pregabalin, Methylcobalamin and Alpha Lipoic Acid in Multicomponent Dosage Form. Int. J. Pharm. Sci. Res. 2016, 7, 2458–2464. 10.13040/IJPSR.0975-8232.7(6).2458-64.
   Web of Science ®Google Scholar
• Salman, K.; Alrassol, A. B. D.; Mousa, M. N. Estimation and Evaluation of Gabapentin and Pregabaline Anti-Epileptic Drugs in Bulk and Pharmaceutical Preparations by Eco-Friendly Bromate-Bromide Reagent. Eurasian J. Anal. Chem. 2019, 14, 10–20.
   Google Scholar
• Sher, N.; Fatima, N.; Perveen, S.; Siddiqui, F. A.; Sial, A. W. Pregabalin and Tranexamic Acid Evaluation by Two Simple and Sensitive Spectrophotometric Methods. Int. J. Anal. Chem. 2015, 2015, 241412–241417. DOI: 10.1155/2015/241412.
   PubMed Web of Science ®Google Scholar
• Patel, R. K.; Golwala, D.; Gohil, N. B. A Novel Spectrophotometric and RP-HPLC Methods for Determination of Nortriptyline Hydrochloride and Pregabalin in Tablets. Int. J. Pharm. Res. Allied Sci. 2020, 9, 1–9.
   Web of Science ®Google Scholar
• Bharatheesha, B.; Gurupadayya, B.; Ambekar, W.; Hashmi, S. Extractive Spectrophotometric Determination of Etoricoxib in Bulk and Pharmaceutical Formulations. Int. J. Chem. Sci. 2007, 5, 2119–2124. 10.1081/AL-120024645.
   Google Scholar
• Manideep, G.; Shane, N. L. J.; Pai, G.; Sathyanarayana, M. B. Development and Validation of a UV Spectroscopic Method to Estimate Etoricoxib in Bulk and Tablet Formulation. Res. J. Pharm. Technol. 2018, 11, 758–760. DOI: 10.5958/0974-360X.2018.00142.7.
   Google Scholar
• Jat, R. K.; Chhipa, R. C.; Sharma, S. Spectrophotometric Quantitation of Etoricoxib in Bulk Drug and Tablets Using Hydrotropic Agent. Pharmacophore 2010, 1, 96–102.
   Google Scholar
• Shah, K.; Gupta, A.; Mishra, P. Extractive Spectrophotometric Methods for the Determination of Etoricoxib in Tablets. E-J. Chem. 2009, 6, 207–212. DOI: 10.1155/2009/280961.
   Google Scholar
• Chaple, D.; Bhusari, K. Spectrophotometric Methods for the Determination of Etoricoxib in Pharmaceutical Formulations. Res. J. Pharm. Technol. 2009, 2, 597–598. 10.1155/2009/280961.
   Google Scholar
• Sunitha, P. G.; Deattu, N.; Ravi Kumar, R.; Sri Rudhra, R.; Kalaimathi, P.; Soundiramani, B. Charge Transfer Complex Method for the Estimation of Etoricoxib in Tablets. J. Drug Deliv. Ther. 2013, 3, 98–99.
   Google Scholar
• Sunitha, P. G.; Deattu, N.; Kumar, R. R.; Rudhra, S. S.; Kalaimathi, P.; Soundiramani, B. Development and Validation of Spectrophotometric Methods for Quantification of Etoricoxib in Tablets. Ann. Chem. Med. Sci. 2015, 1, 36–38.
   Google Scholar
• Choudhari, V. P.; Parekar, S. R.; Chate, S. G.; Bharande, P. D.; Kuchekar, B. S. Development and Validation of UV-Visible Spectrophotometric Baseline Manipulation Methodology for Simultaneous Analysis of Drotraverine and Etoricoxib in Pharmaceutical Dosage Forms. Pharm. Methods. 2011, 2, 247–252. DOI: 10.4103/2229-4708.93395.
   PubMedGoogle Scholar
• Syal, P. K.; Sahoo, M.; Mehendre, D. M.; Ingale, S. S.; Choudhari, V. P.; Kuchekar, B. S. Simultaneous Spectrophotometric Determination of Drotaverine and Etoricoxib in Combined Tablet Dosage Form by Ratio Derivative and Absorption Corrected Method and Its Application to Dissolution Study. Res. J. Pharm. Technol. 2011, 4, 298–301.
   Google Scholar
• Patel, A. B.; Vaghasiya, E.; Vyas, A. J.; Patel, A. I.; Patel, N. K. Spectrophotometric First Order Derivative Method for Simultaneous Determination of Etoricoxib and Paracetamol in Tablet Dosage Form. J. Med. Chem. Sci. 2020, 3, 300–307. 10.26655/jmchemsci.2020.3.9.
   Google Scholar
• Acharjya, S. K.; Rajesh, Y.; Panda, P.; Mallick, P.; Annapurna, M. M. Spectrophotometric Methods for Simultaneous Estimation of Etoricoxib and Thiocolchicoside in Bulk and Combined Pharmaceutical Dosage Form. J. Pharm. Educ. Res. 2010, 1, 75–82. 10.4103/2229-5186.82974.
   Google Scholar
• Singh, S.; Mishra, A.; Verma, A.; Ghosh, A. K.; Mishra, A. K. A Simple Ultraviolet Spectrophotometric Method for the Determination of Etoricoxib in Dosage Formulations. J. Adv. Pharm. Technol. Res. 2012, 3, 237–240. DOI: 10.4103/2231-4040.104715.
   PubMedGoogle Scholar
• Purneshwar, P. B.; Annapurna, M. M.; Anusha, N. New Spectrophotometric Methods for the Assay of Etoricoxib. Asian J. Pharm 2018, 12, S709–S712.
   Web of Science ®Google Scholar
• Suhagiaa, B. N.; Patel, H. M.; Rathod, I. S.; Marolia, B. P. Spectrophotometric Estimation of Etoricoxib in Bulk Drug and Dosage Forms. Indian J. Pharm. Sci. 2005, 67, 634–637.
   Google Scholar
• Ashok, S.; Khalaf, N. High Performance Liquid Chromatographic and Ultra Violet Spectroscopic Determination of Etoricoxib in Pharmaceutical Formulations. Asian J. Chem. 2007, 19, 2059–2069.
   Google Scholar
• More, S.; Tamboli, A.; Amol, V.; Patil, S. HPTLC Method Development for the Simultaneous Determination of Pregabalin and Amitriptyline Hydrochloride in Pharmaceutical Dosage. J. Drug Deliv. Ther. 2019, 9, 348–354. https://doi.org/10.22270/jddt.v9i2-s.2528.
   Google Scholar
• Prasad, M. K. C.; Sagar, G. V.; Sudhakar, P. Simultaneous HPTLC Method for Estimation of Gabapentin and Pregabalin. Int. J. Pharm. Pharm. Sci. 2013, 5, 326–333.
   Google Scholar
• Maheshwari, G.; Subramanian, G. S.; Karthik, A.; Ranjithkumar, A.; Musmade, P.; Ginjupalli, K.; Udupa, N. High-Performance Thin-Layer Chromatographic Determination of Etoricoxib in the Bulk Drug and in Pharmaceutical Dosage Form. J. Planar Chromatogr. Mod. TLC 2007, 20, 335–339. DOI: 10.1556/JPC.20.2007.5.5.
   Web of Science ®Google Scholar
• Chaube, P. H.; Gandhi, S. V.; Deshnande, P. B.; Kulkarni, V. G. High Performance Thin Layer Chromatographic Analysis of Paracetamol and Etoricoxib in Spiked Human Plasma. Res. J. Pharm. Technol. 2011, 4, 1303–1306.
   Google Scholar
• Starek, M.; Rejdych, M. Densitometric Analysis of Celecoxib, Etoricoxib and Valdecoxib in Pharmaceutical Preparations. J. Planar Chromatogr. 2009, 22, 399–403. DOI: 10.1556/JPC.22.2009.6.2.
   Web of Science ®Google Scholar
• Rajmane, V. S.; Gandhi, S. V.; Patil, U. P.; Sengar, M. R. High-Performance Thin-Layer Chromatographic Determination of Etoricoxib and Thiocolchicoside in Combined Tablet Dosage Form. J. AOAC Int. 2010, 93, 783–786. 10.1093/jaoac/93.3.783.
   PubMed Web of Science ®Google Scholar
• Shah, N. J.; Shah, S. J.; Patel, D. M.; Patel, N. M. Development and Validation of HPTLC Method for the Estimation of Etoricoxib. Indian J. Pharm. Sci. 2006, 68, 788–789. DOI: 10.4103/0250-474X.31016.
   Google Scholar
• Dhaneshwar, S.; Raut, K.; Bhusari, V. Validated HPTLC Method for Simultaneous Estimation of Paracetamol and Etoricoxib in Bulk Drug and Formulation. Asian J. Pharm. Biol. Res. 2011, 1, 87–93. 10.1515/revac-2011-0037.
   Google Scholar
• Sowjanya, P. RP HPLC Method Development of Pregabalin in Bulk, Dosage Form and Validation Parameters. Res. Rev. J. Hosp. Clin. Pharm. 2016, 2, 61–75.
   Google Scholar
• Kasawar, G. B.; Farooqui, M. N. Development and Validation of HPLC Method for the Determination of Pregabalin in Capsules. Indian J. Pharm. Sci. 2010, 72, 517–519. DOI: 10.4103/0250-474X.73935.
   PubMed Web of Science ®Google Scholar
• Balaji, J.; Ramachandra, B.; Naidu, N. V. S. Analytical RP-HPLC Method for Development and Validation of Pregabalin in Bulk and the Determination of Pregabalin in Capsule Dosage Form. Int. J. Innov. Res. Sci. Eng. Technol. 2014, 3, 11094–11098.
   Google Scholar
• Ahmadkhaniha, R.; Mottaghi, S.; Zargarpoor, M.; Souri, E. Validated HPLC Method for Quantification of Pregabalin in Human Plasma Using 1-Fluoro-2,4-Dinitrobenzene as Derivatization Agent. Chromatogr. Res. Int. 2014, 2014, 1–6. DOI: 10.1155/2014/450461.
   Google Scholar
• Akther, H.; Morshed, M. M.; Islam, M. M.; Hassan, J.; Barua, B. P.; Bin, E. T. Development of a Method and Its Validation for Estimation of Pregabaline in Pharmaceutical and Bulk Formulation. Biomed. Sci. Today 2015, 1–8.
   Google Scholar
• Pingale, P.; Singasane, T. Development and Validation of HPLC Method for the Determination of Pregabalin in Bulk and in Pharmaceutical Formulations. Res. J. Pharm. Technol. 2012, 5, 829–833.
   Google Scholar
• Arayne, S.; Sultana, N.; Shehnaz, H.; Haider, A. Monitoring of Pregabalin in Pharmaceutical Formulations and Human Serum Using UV and RP-HPLC Techniques: Application to Dissolution Test Method. Pharm. Anal. Acta 2014, 5,1–7. 10.4172/2153-2435.1000287.
   PubMedGoogle Scholar
• Ashutosh Kumar, S.; Debnath, M.; Seshagiri Rao, J. V. L. N.; Gowri Sankar, D. Stability Indicating Analytical Method Development and Validation for Simultaneous Estimation of Pregabalin, Mecobalamin and Alpha Lipoic Acid in Bulk as Well as in Pharmaceutical Dosage Form by Using RP-HPLC. Res. J. Pharm. Technol. 2014, 7, 1004–1013.
   Google Scholar
• Sreekanth, D.; Ramya, P.; Vishwanadham, Y.; Vanitha, R. Development and Method Validation of RP-HPLC for Simultaneous Determination of Pregabalin and Methylcobalamin in Pure and Pharmaceutical Dosage Form. Asia. J. Res. Chem. 2017, 10, 557. DOI: 10.5958/0974-4150.2017.00092.X.
   Google Scholar
• Narmada, P.; Vijaya Lakshmi, G.; Nalini, G.; Gowtham, Y.; Suhasini, B.; Jogi, K. V. RP-HPLC Method Development and Validation for the Determination of Methylcobalamin and Pregabalin in Combined Capsule Dosage Form. Int. J. Res. Pharm. Sci. 2013, 4, 25–29.
   Google Scholar
• Kannapan, N.; Nayak, S. P.; Venkatachalam, T.; Prabhakaran, V. Analytical RP-HPLC Method for Development and Validation of Pregabalin and Methylcobalamine in Combined Capsule Formulation Analytical RP-HPLC Method for Development and Validation of Pregabalin and Methylcobalamine in Combined Capsule Formulation. J. Appl. Chem. Res. 2010, 13, 85–89.
   Google Scholar
• Kavitha, M.; Rajasekhar, A. A Validated HPLC Method for the Analysis of Pregabalin and Methylcobalamin in Bulk and Pharmaceutical Formulation. Pharm. Glob. Int. J. Compr. Pharm. 2013, 7, 1–5.
   Google Scholar
• Khanage, S. G.; Kale, D. S.; Mohite, P. B.; Deshmukh, V. K. Reversed Phase High Performance Liquid Chromatographic Method for Simultaneous Estimation of Pregabalin and Aceclofenac in Tablet Formulation (Acenac-N). J. Rep. Pharm. Sci. 2014, 3, 184–192. 10.22110/jrps.v3i2.2063.
   Google Scholar
• Potluri, H.; Battula, S. R.; Yeturu, S. Validated Stability Indicating RP-HPLC Method for Simultaneous Determination of Nortriptyline and Pregabalin in Bulk and Combined Dosage Formulations. J. Chil. Chem. Soc. 2017, 62, 3490–3495. DOI: 10.4067/S0717-97072017000200013.
   Web of Science ®Google Scholar
• Kumar, N.; Kalyanaraman, L.; Tilavat, D.; Sangeetha, D. Development and Validation of a Simple and Rapid Reversed Phase Liquid Chromatography Method for Estimation of Pregabalin from Equipment Surfaces Used for Pharmaceutical Manufacturing. Ann. Chromatogr. Sep. Tech. 2016, 2, 1023–1028.
   Google Scholar
• Janmajoy, B.; Padmalatha Rahul; Ranabir, C. Method Development and Validation for the Simultaneous Estimation of Eplarestat and Pragabalin in Bulk and Pharmaceutical Formulation by Using RP-HPLC. Asian J. Pharm. Anal. 2018, 8, 174–180. DOI: 10.5958/2231-5675.2018.00032.7.
   Google Scholar
• Atta, A. M.; Salama, I.; Gomaa, M. S.; Mostafa, S. A New HPLC Method for Simultaneous Determination of Atenolol and Pregabalin in Dosage Forms and Human Urine. Int. J. Pharm. Chem. Biol. Sci. 2016, 6, 48–61.
   Google Scholar
• Sravanthi, T.; Madhavi, N. Stability Indicating UPLC Method for Simultaneous Estimation of Epalrestat and Pregabalin in Tablet Dosage Form. Res. J. Pharm. Technol. 2019, 12, 489–494. DOI: 10.5958/0974-360X.2019.00086.6.
   Google Scholar
• Gelani, H. D.; Chauhan, P. P.; Shah, S. K. Practical Implication of Chromatographic Method for Estimation of Aceclofenac and Pregabalin in Bulk and Pharmaceutical Dosage Forms. Chromatogr. Res. Int. 2014, 2014, 1–5. DOI: 10.1155/2014/643027.
   Google Scholar
• Mathesan, R.; Alexander, S.; Shankar, M.; Jeyaseeli Florance, E. Method Development and Validation of Aceclofenac and Pregabalin in Marketed Formulation by UPLC Method. Acta Biomed. Sci. 2020, 7, 25–30. 10.21276/abs.2020.7.1.5.
   Google Scholar
• Seema, A.; Jeeja, P.; Ashish, J. Development and Validation of HPLC Method for Estimation of Pregabalin in Bulk & Capsule Dosage Form. Pharm. Anal. Acta 2016, 7, 1–6. 10.4172/2153-2435.1000492.
   Google Scholar
• Ramakrishna, N. V. S.; Vishwottam, K. N.; Wishu, S.; Koteshwara, M. Validated Liquid Chromatographic Ultraviolet Method for the Quantitation of Etoricoxib in Human Plasma Using Liquid-Liquid Extraction. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2005, 816, 215–221. DOI: 10.1016/j.jchromb.2004.11.034.
   PubMed Web of Science ®Google Scholar
• Mandal, U.; Rajan, D. S.; Bose, A.; Gowda, K. V.; Ghosh, A.; Pal, T. K. Development and Validation of an HPLC Method for Analysis of Etoricoxib in Human Plasma. Indian J. Pharm. Sci. 2006, 68, 485–489. DOI: 10.4103/0250-474X.27823.
   Google Scholar
• Singh, B.; Santhakumar, R.; Bala, I.; Prasad, S. B.; Verma, S. Development and Validation of RP-HPLC Method for the Dissolution and Assay of Etoricoxib in Pharmaceutical Dosage Forms. Int. J. Pharm. Qual. Assur. 2015, 6, 1–7.
   Google Scholar
• Bhattacharyya, I.; Bhattacharyya, S. P.; Sen, S.; Laha, T. K. Reverse Phase High Performance Liquid Chromatographic Method for the Analysis of Etoricoxib in Pharmaceutical Dosage Form. Asian J. Res. Chem. 2009, 2, 297–299.
   Google Scholar
• Hartman, R.; Abrahim, A.; Clausen, A.; Mao, B.; Crocker, L. S.; Ge, Z. Development and Validation of an HPLC Method for the Impurity and Quantitative Analysis of Etoricoxib. J. Liq. Chromatogr. Relat. Technol. 2003, 26, 2551–2566. DOI: 10.1081/JLC-120023800.
   Web of Science ®Google Scholar
• Radwan, M. A.; Zaghloul, I. Y.; Abd Elbaky, N. A. Stability Indicating High Performance Liquid Chromatographic Assay for the Pharmacokinetics of Cyclooxygenase (COX-2) Inhibitor Etoricoxib in Rats. Afr. J. Pharm. Pharmacol. 2009, 3, 339–346.
   Google Scholar
• Topalli, S.; Chandrashekhar, T. G.; Annapurna, M. M. Validated RP- HPLC Method for the Assay of Etoricoxib (a Non-Steroidal anti-Inflammatory Drug) in Pharmaceutical Dosage Forms. E-J. Chem. 2012, 9, 832–838. DOI: 10.1155/2012/264567.
   Google Scholar
• Alzweiri, M.; Sallam, M.; Al-Zyoud, W.; Aiedeh, K. Stability Study of Etoricoxib a Selective Cyclooxygenase-2 Inhibitor by a New Single and Rapid Reversed Phase HPLC Method. Symmetry. 2018, 10, 288. DOI: 10.3390/sym10070288.
   Google Scholar
• Haque, M.; Nasrin, S.; Monir, M. Method Development and Validation of RP-HPLC Method of Etoricoxib in Bulk and Its Tablet Dosage Forms. American Journal of PharmTech Research, 2012, 2,275–283.
   Google Scholar
• Zaveri, M.; Khandhar, A. Quantitative Determination of Etoricoxib and Paracetamol in Pharmaceutical Dosage. Asian J. Pharm. Res. Heal. Care 2010, 2, 307–313.
   Google Scholar
• Pattan, S. R.; Jamdar, S. G.; Godge, R. K.; Dighe, N. S.; Daithankar, A. V.; Nirmal, S. A.; Pai, M. G. RP-HPLC Method for Simultaneous Estimation of Paracetamol and Etoricoxib from Bulk and Tablets. J. Chem. Pharm. Res. 2009, 1, 329–335.
   Google Scholar
• Kumar, S.; Joshi, A.; Thakur, R. S.; Pathak, A. K.; Shah, K. Simultaneous Estimation of Etoricoxib and Thiocolchicoside by RP-HPLC Method in Combined Dosage Forms. Acta Pol. Pharm. Drug Res. 2011, 68, 839–843.
   PubMed Web of Science ®Google Scholar
• Venugopal, S.; Tripathi, U. M.; Devanna, N. Validated Reverse Phase HPLC Method for the Determination of Impurities in Etoricoxib. E-J. Chem. 2011, 8, 119–127. 10.1155/2011/726385.
   Google Scholar
• Gupta, K. R.; Likhar, A. D.; Wadodkar, S. G. Application of Stability Indicating HPLC Method for Quantitative Determination of Etoricoxib and Paracetamol in Pharmaceutical Dosage Form. Eurasian J. Anal. Chem. 2011, 5, 218–226.
   Google Scholar
• Gangane, P. S.; Bagde, S. M.; Mujbaile, S. G.; Niranjane, K. D. Development and Validation of HPLC Assay Method for Etoricoxib in Bulk Drug and Tablet Formulation. JCPR 2014, 4, 1286–1625. DOI: 10.33786/JCPR.2014.v04i04.004.
   Google Scholar
• Bagade, S. B.; Meshram, D. B.; Tajne, M. R. Estimation of Etoricoxib in Tablet Dosage Form by RP-HPLC Using Internal Standard with Emphasize on Specificity Parameter Method. Orient. J. Chem. 2011, 27, 697–701.
   Google Scholar
• Parameswara Rao, K.; Ramana, G. V. Cost Effective Isocratic RP-HPLC Method for Simultaneous Determination of Etoricoxib and Paracetamol in Pure and in Tablet Formulation. J. Adv. Stud. Agric. Biol. Environ. Sci. 2014, 1, 201–209.
   Google Scholar
• Pavan Kumar, V. V.; Vinu, M. C. A.; Ramani, A. V.; Mullangi, R.; Srinivas, N. R. Simultaneous Quantitation of Etoricoxib, Salicylic Acid, Valdecoxib, Ketoprofen, Nimesulide and Celecoxib in Plasma by High-Performance Liquid Chromatography with UV Detection. Biomed. Chromatogr. 2006, 20, 125–132. DOI: 10.1002/bmc.539.
   PubMed Web of Science ®Google Scholar
• Patel, H. M.; Suhagia, B. N.; Shah, S. A.; Rathod, I. S. Determination of Etoricoxib InPharmaceutical Formulation by HPLC Method. Indian J. Pharm. Sci. 2007, 69, 703–705. DOI: 10.4103/0250-474X.38485.
   Google Scholar
• Narajji, C.; Karvekar, M. D. Method Development and Validation for Simultaneous Estimation of Paracetamol and Etoricoxib in Pharmaceutical Dosage Form by RP-HPLC Method. Der Pharm. Chem. 2011, 3, 7–12.
   Google Scholar
• Patel, P. N.; Samanthula, G.; Shrigod, V.; Modh, S. C.; Chaudhari, J. R. RP-HPLC Method for Determination of Several NSAIDs and Their Combination Drugs. Chromatogr. Res. Int. 2013, 2013, 1–13. DOI: 10.1155/2013/242868.
   Google Scholar
• Andraws, G.; Trefi, S. Ionisable Substances Chromatography: A New Approach for the Determination of Ketoprofen, Etoricoxib, and Diclofenac Sodium in Pharmaceuticals Using Ion – Pair HPLC. Heliyon 2020, 6, e04613. DOI: 10.1016/j.heliyon.2020.e04613.
   PubMed Web of Science ®Google Scholar
• Lakshmana Prabu, S.; Annie, S.; Dinesh Kumar, C.; Shirwaikar, A.; Kumar, A. Development and Validation of RP-HPLC Method for the Estimation of Etoricoxib in Bulk and Tablets. Indian Drugs 2009, 46, 56–58.
   Google Scholar
• Kotadiya, R. M.; Patel, F. N. Analytical Methods Practiced to Quantitation of Rifampicin: A Captious Survey. Curr. Pharm. Anal. 2020. 10.2174/1573412916999200704144231.
   Web of Science ®Google Scholar
• Tafesse, T. B.; Mazdeh, F. Z.; Chalipour, A.; Tavakoli, M.; Hajimahmoodi, M.; Amini, M. Gas Chromatography–Mass Spectrometry Determination of Pregabalin in Human Plasma Using Derivatization Method. Chromatographia 2018, 81, 501–508. DOI: 10.1007/s10337-017-3458-0.
   Web of Science ®Google Scholar
• Vaidya, V.; Yetal, S.; Roy, S.; Gomes, N.; Joshi, S. LC-MS-MS Determination of Pregabalin in Human Plasma. Chroma. 2007, 66, 925–928. DOI: 10.1365/s10337-007-0430-4.
   Web of Science ®Google Scholar
• Thompson, A.; Morey, S.; Griffiths, A. Pregabalin and Its Involvement in Coronial Cases. J. Anal. Toxicol. 2020, 44, 29–35. 10.1093/jat/bkz041.
   PubMed Web of Science ®Google Scholar
• Jadhav, A. S.; Pathare, D. B.; Shingare, M. S. Validated Enantioselective LC Method, with Precolumn Derivatization with Marfey’s Reagent, for Analysis of the Antiepileptic Drug Pregabalin in Bulk Drug Samples. Chroma. 2007, 65, 253–256. DOI: 10.1365/s10337-006-0152-z.
   Web of Science ®Google Scholar
• Pauly, C.; Yegles, M.; Schneider, S. Pregabalin Determination in Hair by Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry. J. Anal. Toxicol. 2013, 37, 676–679. DOI: 10.1093/jat/bkt081.
   PubMed Web of Science ®Google Scholar
• De La Vega, H.; Fox, K.; Pardi, J.; Santiago-Tirado, W.; Cooper, G. Validation of a High-Throughput Screening and Quantification Method for the Determination of Gabapentinoids in Blood Using a Combination of LC-TOF-MS and LC-MS-MS. J. Anal. Toxicol. 2019, 43, 696–702. DOI: 10.1093/jat/bkz070.
   PubMed Web of Science ®Google Scholar
• Orfanidis, A.; Gika, H.; Theodoridis, G.; Mastrogianni, O.; Raikos, N. Development of a UHPLC-MS/MS Method for the Determination of 84 Pharmaceuticals and Drugs of Abuse in Human Liver. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2020, 1151, 122192. DOI: 10.1016/j.jchromb.2020.122192.
   PubMed Web of Science ®Google Scholar
• Nirogi, R.; Kandikere, V.; Mudigonda, K.; Komarneni, P.; Aleti, R. Liquid Chromatography Atmospheric Pressure Chemical Ionization Tandem Mass Spectrometry Method for the Quantification of Pregabalin in Human Plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877, 3899–3906. DOI: 10.1016/j.jchromb.2009.10.004.
   PubMed Web of Science ®Google Scholar
• Nahar, L.; Smith, A.; Patel, R.; Andrews, R.; Paterson, S. Validated Method for the Screening and Quantification of Baclofen, Gabapentin and Pregabalin in Human Post-Mortem Whole Blood Using Protein Precipitation and Liquid Chromatography-Tandem Mass Spectrometry. J. Anal. Toxicol. 2017, 41, 441–450. DOI: 10.1093/jat/bkx019.
   PubMed Web of Science ®Google Scholar
• Jang, K.; Seo, J.; Yim, S.; Lee, K. Rapid and Simple Method for the Determination of Pregabalin in Human Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS): Application to a Bioequivalence Study of Daewoong Pregabalin Capsule to Lyrica ® Capsule (Pregabalin 150 Mg). J. Pharm. Investig. 2011, 41, 255–262. DOI: 10.4333/KPS.2011.41.4.255.
   Google Scholar
• Karavadi, T. M.; Challa, B. R. Bioanalytical Method Development and Validation of Pregabalin in Rat Plasma by Solid Phase Extraction with HPLC-MS/MS: Application to a Pharmacokinetic Study. J. Liq. Chromatogr. Relat. Technol. 2014, 37, 130–144. DOI: 10.1080/10826076.2012.738617.
   Web of Science ®Google Scholar
• Shah, G. R.; Ghosh, C.; Thaker, B. T. Determination of Pregabalin in Human Plasma by Electrospray Ionisation Tandem Mass Spectroscopy. J. Adv. Pharm. Technol. Res. 2010, 1, 354–357. DOI: 10.4103/0110-5558.72423.
   PubMedGoogle Scholar
• Hložek, T.; Bursová, M.; Coufal, P.; Čabala, R. Gabapentin, Pregabalin and Vigabatrin Quantification in Human Serum by GC-MS after Hexyl Chloroformate Derivatization. J. Anal. Toxicol. 2016, 40, 749–753. 10.1093/jat/bkw070.
   PubMed Web of Science ®Google Scholar
• Aji, A.; Karthikeyan, S.; Singh, S.; Puthli, S. P. A Novel UPLC-MS/MS Method for Determination of γ-Amino Butyric Acid Analogue in Human Plasma: Application to Pharmacokinetic Study. J. Appl. Pharm. Sci. 2013, 3, 172–178. 10.7324/JAPS.2013.3630.
   Google Scholar
• Chahbouni, A.; Sinjewel, A.; Jeroen, J. C.; Vos, R. M.; Wilhelm, A. J.; Veldkamp, A. I.; Swart, E. L. Rapid Quantification of Gabapentin, Pregabalin, and Vigabatrin in Human Serum by Ultraperformance Liquid Chromatography with Mass-Spectrometric Detection. Ther. Drug Monit. 2013, 35, 48–53. 10.1097/FTD.0b013e31827788c0.
   PubMed Web of Science ®Google Scholar
• Dahl, S. R.; Olsen, K. M.; Strand, D. H. Determination of Gamma-Hydroxybutyrate (GHB), Beta-Hydroxybutyrate (BHB), Pregabalin, 1,4-Butane-Diol (1,4BD) and Gamma-Butyrolactone (GBL) in Whole Blood and Urine Samples by UPLC-MSMS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2012, 885–886, 37–42. DOI: 10.1016/j.jchromb.2011.12.009.
   PubMed Web of Science ®Google Scholar
• Mandal, U.; Sarkar, A. K.; Gowda, K. V.; Agarwal, S.; Bose, A.; Bhaumik, U.; Ghosh, D.; Pal, T. K. Determination of Pregabalin in Human Plasma Using LC-MS-MS. Chroma. 2008, 67, 237–243. DOI: 10.1365/s10337-007-0440-2.
   Web of Science ®Google Scholar
• Oertel, R.; Arenz, N.; Pietsch, J.; Kirch, W. Simultaneous Determination of Three Anticonvulsants Using Hydrophilic Interaction LC-MS. J. Sep. Sci. 2009, 32, 238–243. DOI: 10.1002/jssc.200800461.
   PubMed Web of Science ®Google Scholar
• Dżygiel, P.; Fraier, D. Simultaneous Determination of Pregabalin, Sildenafil and Its Active Metabolite in Rat Plasma Utilising SPE Followed by LC-MS-MS. Chromatographia 2011, 73, 1177–1182. DOI: 10.1007/s10337-011-2004-8.
   Web of Science ®Google Scholar
• Mudiam, M. K. R.; Chauhan, A.; Jain, R.; Ratnasekhar, C.; Fatima, G.; Malhotra, E.; Murthy, R. C. Development, Validation and Comparison of Two Microextraction Techniques for the Rapid and Sensitive Determination of Pregabalin in Urine and Pharmaceutical Formulations after Ethyl Chloroformate Derivatization Followed by Gas Chromatography-Mass Spectrometric Analysis. J. Pharm. Biomed. Anal. 2012, 70, 310–319. DOI: 10.1016/j.jpba.2012.05.001.
   PubMed Web of Science ®Google Scholar
• Chennuru, L. N.; Choppari, T.; Nandula, R. P.; Zhang, T.; Franco, P. Direct Separation of Pregabalin Enantiomers Using a Zwitterionic Chiral Selector by High Performance Liquid Chromatography Coupled to Mass Spectrometry and Ultraviolet Detection. Molecules 2016, 21, 1578. DOI: 10.3390/molecules21111578.
   PubMed Web of Science ®Google Scholar
• Priez-Barallon, C.; Carlier, J.; Boyer, B.; Benslima, M.; Fanton, L.; Mazoyer, C.; Gaillard, Y. Quantification of Pregabalin Using Hydrophilic Interaction Hplc-High-Resolution Ms in Postmortem Human Samples: Eighteen Case Reports. J. Anal. Toxicol. 2014, 38, 143–148. DOI: 10.1093/jat/bku004.
   PubMed Web of Science ®Google Scholar
• Di Rago, M.; Saar, E.; Rodda, L. N.; Turfus, S.; Kotsos, A.; Gerostamoulos, D.; Drummer, O. H. Fast Targeted Analysis of 132 Acidic and Neutral Drugs and Poisons in Whole Blood Using LC-MS/MS. Forensic Sci. Int. 2014, 243, 35–43. DOI: 10.1016/j.forsciint.2014.03.021.
   PubMed Web of Science ®Google Scholar
• Deeb, S.; McKeown, D. A.; Torrance, H. J.; Wylie, F. M.; Logan, B. K.; Scott, K. S. Simultaneous Analysis of 22 Antiepileptic Drugs in Postmortem Blood, Serum and Plasma Using LC-MS-MS with a Focus on Their Role in Forensic Cases. J. Anal. Toxicol. 2014, 38, 485–494. DOI: 10.1093/jat/bku070.
   PubMed Web of Science ®Google Scholar
• Hegstad, S.; Hermansson, S.; Betnér, I.; Spigset, O.; Falch, B. M. H. Screening and Quantitative Determination of Drugs of Abuse in Diluted Urine by UPLC-MS/MS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2014, 947–948, 83–95. DOI: 10.1016/j.jchromb.2013.12.014.
   PubMed Web of Science ®Google Scholar
• Sørensen, L. K.; Hasselstrøm, J. B. Determination of Therapeutic γ-Aminobutyric Acid Analogs in Forensic Whole Blood by Hydrophilic Interaction Liquid Chromatography-Electrospray Tandem Mass Spectrometry. J. Anal. Toxicol. 2014, 38, 177–183. DOI: 10.1093/jat/bku010.
   PubMed Web of Science ®Google Scholar
• Brum, L.; Ceni, D. C.; Fronza, M.; De Oliveira, P. R.; Dalmora, S. L. Validation of an LC-Tandem MS/MS Method for the Determination of Etoricoxib in Human Plasma and Pharmaceutical Formulations. J. Liq. Chromatogr. Relat. Technol. 2006, 29, 123–135. DOI: 10.1080/10826070500364306.
   Web of Science ®Google Scholar
• Brum, L.; Fronza, M.; Ceni, D. C.; Barth, T.; Dalmora, S. L. Validation of Liquid Chromatography and Liquid Chromatography/Tandem Mass Spectrometry Methods for the Determination of Etoricoxib in Pharmaceutical Formulations. J. AOAC Int. 2006, 89, 1268–1275. DOI: 10.1093/jaoac/89.5.1268.
   PubMed Web of Science ®Google Scholar
• Dalmora, S. L.; Junior, L. B.; Ferretto, R. M.; Oliveira, P. R. d.; Barth, T.; Sangoi, M. d. S. Determination of Etoricoxib in Human Plasma Using Automated on-Line Solid-Phase Extraction Coupled with LC-APCI/MS/MS. Quím. Nova 2008, 31, 574–578. DOI: 10.1590/S0100-40422008000300021.
   Web of Science ®Google Scholar
• Vora, D. N.; Kadav, A. A. Separation of Etoricoxib and Its Degradation Products in Drug Substance Using UPLC TM. Eurasian J. Anal. Chem. 2007, 2, 151–158.
   Google Scholar
• Werner, U.; Werner, D.; Hinz, B.; Lambrecht, C.; Brune, K. A Liquid Chromatography-Mass Spectrometry Method for the Quantification of Both Etoricoxib and Valdecoxib in Human Plasma. Biomed. Chromatogr. 2005, 19, 113–118. DOI: 10.1002/bmc.423.
   PubMed Web of Science ®Google Scholar
• Bräutigam, L.; Nefflen, J. U.; Geisslinger, G. Determination of Etoricoxib in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry with Electrospray Ionisation. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2003, 788, 309–315. DOI: 10.1016/S1570-0232(03)00034-5.
   PubMed Web of Science ®Google Scholar
• Gika, H. G.; Theodoridou, A.; Michopoulos, F.; Theodoridis, G.; Diza, E.; Settas, L.; Nikolaidis, P.; Smith, C.; Wilson, I. D. Determination of Two COX-2 Inhibitors in Serum and Synovial Fluid of Patients with Inflammatory Arthritis by Ultra Performance Liquid Chromatography-Inductively Coupled Plasma Mass Spectroscopy and Quadrupole Time-of-Flight Mass Spectrometry. J. Pharm. Biomed. Anal. 2009, 49, 579–586. DOI: 10.1016/j.jpba.2008.12.006.
   PubMed Web of Science ®Google Scholar
• Rose, M. J.; Agrawal, N.; Woolf, E. J.; Matuszewski, B. K. Simultaneous Determination of Unlabeled and Carbon-13-Labeled Etoricoxib, a New Cyclooxygenase-2 Inhibitor, in Human Plasma Using HPLC-MS/MS. J. Pharm. Sci. 2002, 91, 405–416. DOI: 10.1002/jps.10038.
   PubMed Web of Science ®Google Scholar
• Zhang, X.; Guo, N.; Ji, W.; Wen, Q. Rapid Quantitative Analysis of Etoricoxib in Human Plasma by UPLC-MS/MS and Application to a Pharmacokinetic Study in Chinese Healthy Volunteers. Biomed. Chromatogr 2019. DOI: 10.1002/bmc.4414.
   Web of Science ®Google Scholar
• Jalakam, S. P.; Waghmode, J.; Pawar, P.; Shinde, D.; Mane, G. Development of Simple and Rapid LC-MS/MS Method for Determination of Etoricoxib in Human Plasma and Its Application to Bioequivalence Study. Biomirror 2016, 7, 11–16.
   Google Scholar
• Ibrahim, F. A.; Elmansi, H.; Fathy, M. E. Green RP-HPLC Method for Simultaneous Determination of Moxifloxacin Combinations: Investigation of the Greenness for the Proposed Method. Microchem. J. 2019, 148, 151–161. DOI: 10.1016/j.microc.2019.04.074.
   Web of Science ®Google Scholar
• Pacheco-Fernández, I.; Pino, V. Green Solvents in Analytical Chemistry. Curr. Opin. Green Sustain. Chem. 2019, 18, 42–50. DOI: 10.1016/j.cogsc.2018.12.010.
   Web of Science ®Google Scholar
• Welton, T. Solvents and Sustainable Chemistry. Proc. R. Soc. A Math. Phys. Eng. Sci. 2015, 471, 20150502. 10.1098/rspa.2015.0502.
   Web of Science ®Google Scholar
• Capello, C.; Fischer, U.; Hungerbühler, K. What Is a Green Solvent? A Comprehensive Framework for the Environmental Assessment of Solvents. Green Chem. 2007, 9, 927–993. DOI: 10.1039/b617536h.
   Web of Science ®Google Scholar
• Tobiszewski, M. Metrics for Green Analytical Chemistry. Anal. Methods 2016, 8, 2993–2999. DOI: 10.1039/C6AY00478D.
   Web of Science ®Google Scholar
• de la Guardia, M.; Armenta, S. Green Solvents for Analytical Separation and Analyses. Encycl. Anal. Chem. 2010, 1-20. 10.1002/9780470027318.a9179
   PubMedGoogle Scholar
• Vian, M.; Breil, C.; Vernes, L.; Chaabani, E.; Chemat, F. Green Solvents for Sample Preparation in Analytical Chemistry. Curr. Opin. Green Sustain. Chem. 2017, 5, 44–48. DOI: 10.1016/j.cogsc.2017.03.010.
   Web of Science ®Google Scholar
• Haq, N.; Iqbal, M.; Alanazi, F. K.; Alsarra, I. A.; Shakeel, F. Applying Green Analytical Chemistry for Rapid Analysis of Drugs: Adding Health to Pharmaceutical Industry. Arab. J. Chem. 2017, 10, S777–S785. DOI: 10.1016/j.arabjc.2012.12.004.
   Web of Science ®Google Scholar
• Bazel, Y.; Rečlo, M.; Chubirka, Y. Switchable Hydrophilicity Solvents in Analytical Chemistry. Five Years of Achievements. Microchem. J. 2020, 157, 105115. DOI: 10.1016/j.microc.2020.105115.
   Web of Science ®Google Scholar
• Alam, P.; Ezzeldin, E.; Iqbal, M.; Anwer, M. K.; Mostafa, G. A. E.; Alqarni, M. H.; Foudah, A. I.; Shakeel, F. Ecofriendly Densitometric RP-HPTLC Method for Determination of Rivaroxaban in Nanoparticle Formulations Using Green Solvents. RSC Adv. 2020, 10, 2133–2140. DOI: 10.1039/C9RA07825H.
   PubMed Web of Science ®Google Scholar
• Haq, N.; Shakeel, F.; Alanazi, F.; Alshora, D. H.; Ibrahim, M. A. Development and Validation of a Green RP-HPLC Method for the Analysis of Rosuvastatin: A Step towards Making Liquid Chromatography Environmentally Benign. Green Process. Synth. 2018, 7, 160–169. DOI: 10.1515/gps-2017-0023.
   Web of Science ®Google Scholar